Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Receivables of $2485.0 for Q4 2021, up 77.5% quarter-over-quarter from $1400.0 in Q2 2020.
Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Receivables for 5 consecutive years, with $2485.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Receivables changed N/A year-over-year to $2485.0; the TTM figure through Dec 2021 stood at $2485.0 (changed N/A YoY), while the FY2021 annual figure was $2485.0, changed N/A from the prior year.
- Receivables advanced to $2485.0 in Q4 2021 per CELZ's latest filing, from $1400.0 in the prior quarter.
- Across five years, Receivables topped out at $24500.0 in Q3 2019 and bottomed at $163.0 in Q1 2019.
- Historically, Receivables has averaged $7195.8 across 5 years, with a median of $5200.5 in 2017.
- Annual changes were most pronounced in 2019 — Receivables tumbled 98.3% — and 2020, when it jumped 5053.37%.
- Creative Medical Technology Holdings' Receivables stood at $4801.0 in 2017, then soared by 99.96% to $9600.0 in 2018, then sank by 41.67% to $5600.0 in 2019, then slumped by 75.0% to $1400.0 in 2020, then surged by 77.5% to $2485.0 in 2021.
- Business Quant data shows CELZ's Receivables at $2485.0 in Q4 2021, $1400.0 in Q2 2020, and $8400.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2,485.00 |
| Jun 30, 2020 | 1,400.00 |
| Mar 31, 2020 | 8,400.00 |
| Dec 31, 2019 | 5,600.00 |
| Sep 30, 2019 | 24,500.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 163.00 |
| Dec 31, 2018 | 9,600.00 |
| Sep 30, 2018 | 14,000.00 |
| Jun 30, 2018 | 4,800.00 |
| Mar 31, 2018 | 9,600.00 |
| Dec 31, 2017 | 4,801.00 |